Back to School: How biopharma can reboot drug development. Access exclusive analysis here
The Houston company and Syntex Corp. (Palo Alto, Calif.) will develop gene medicines using non-viral
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury